Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Human Immunodeficiency Virus Screening and Preexposure Prophylaxis.

Created on 17 Jul 2026

Authors

American College of Obstetricians & Gynecologists' Committee on Clinical Consensus—Gynecology

Published in

Obstetrics and gynecology. Volume 148. Issue 2. Pages e150-e158. Aug 01, 2026.

Abstract

Obstetrician-gynecologists (ob-gyns) and other reproductive care professionals are uniquely suited to counsel their patients on human immunodeficiency virus (HIV) screening and HIV preexposure prophylaxis (PrEP) due to their expertise in reproductive health counseling. Ob-gyns and other health care professionals should be obtaining comprehensive sexual health histories, assessing risk behavior, and providing their patients information regarding prevention of sexually transmitted infections such as HIV. When framing their counseling, health care professionals should consider epidemiologic data and HIV prevalence rates for their practice area, and counseling should include discussion of prevention methods. Deciding route of administration and form of PrEP medication should be part of a shared decision-making model between the patient and clinician. By normalizing conversations about HIV prevention, encouraging HIV screening, and ensuring awareness of and access to PrEP, ob-gyns can help reduce disparities in individuals with HIV and those at risk of acquisition.

PMID:
42462257
Bibliographic data and abstract were imported from PubMed on 17 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement